Royalty Pharma plc
RPRX
Kedudukan dalam Saham
#893
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$60.39
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$26.89B
Perubahan (1 hari)
-0.93%
Perubahan (1 tahun)
64.87%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Sejarah hasil dividen untuk Royalty Pharma plc (RPRX)
Hasil dividen (TTM) bagi Royalty Pharma plc (simbol saham: RPRX) pada 2023-12-31 adalah: 2.85%
Purata hasil dividen 5 tahun terakhir: 2.37%
Purata hasil dividen 5 tahun terakhir: 2.37%
Sejarah hasil dividen untuk Royalty Pharma plc (RPRX) dari 2015 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Ubah |
|---|---|---|
| 2026 (TTM) | 1.57% | -52.57% |
| 2024 | 3.31% | 16.14% |
| 2023 | 2.85% | 47.67% |
| 2022 | 1.93% | 11.56% |
| 2021 | 1.73% | -15.61% |
| 2020 | 2.05% | -56.29% |
| 2019 | 4.69% | -9.28% |
| 2018 | 5.17% | 10.94% |
| 2017 | 4.66% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
| Syarikat | Hasil Dividen | Negara |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 2.29% |
HK
|
|
| 0.00% |
US
|
